Short Interest in Procaps Group S.A. (NASDAQ:PROC) Grows By 56.5%

Procaps Group S.A. (NASDAQ:PROC) was the target of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 18,000 shares, a growth of 56.5% from the August 31st total of 11,500 shares. Based on an average trading volume of 5,400 shares, the days-to-cover ratio is presently 3.3 days. Approximately 0.1% of the company’s shares are short sold.

Procaps Group Trading Up 3.2 %

Shares of PROC opened at $2.23 on Friday. The stock has a market capitalization of $251.59 million, a P/E ratio of 4.29 and a beta of 0.15. The firm’s fifty day simple moving average is $2.06 and its two-hundred day simple moving average is $2.49. Procaps Group has a 12 month low of $1.68 and a 12 month high of $4.95.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.